FUB-APINACA

FUB-APINACA is a designer drug that belongs to the cannabinoid class. It is an analogue of APINACA and 5F-APINACA where the isopropyl group is replaced by an isobutyl group.

History

FUB-APINACA was first identified in Japan in 2013. It was among the drugs identified in a patent by Pfizer in 2009, but it was not developed into a medicine. The drug has been sold online as a designer drug.

Pharmacology

FUB-APINACA is believed to be a potent agonist of the CB1 receptor, though the exact mechanism of action is not known. It is structurally related to other cannabinoid compounds such as APINACA and 5F-APINACA.

Legal status

FUB-APINACA is illegal in many countries. It is a controlled substance in China, Germany, the United Kingdom, and the United States.

See also

• List of designer drugs
• List of controlled substances
• Cannabinoid receptor

References

FUB-APINACA Resources
Need Help Finding a Doctor? Need help finding a doctor or specialist anywhere in the world? Explore our world directory. WikiMD's DocFinder can assist you in locating millions of physicians.	Medical Knowledge Access the latest research - Most recent articles Ongoing trials.

Translate to: East Asian 中文, 日本, 한국어, South Asian हिन्दी, Urdu, বাংলা, తెలుగు, தமிழ், ಕನ್ನಡ,
Southeast Asian Indonesian, Vietnamese, Thai, မြန်မာဘာသာ, European español, Deutsch, français, русский, português do Brasil, Italian, polski